Form 483

Bayer AG Form 483, 2019-03-22

FDA issued a Form 483 to Bayer AG on 2019-03-22 with 13 public-safe observations.

483· Form 483 issuedHuman Drugs13 observations

Bayer AG · Leverkusen, Germany · Issued March 22, 2019

Overview

  • 13 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Mar 2019
21 CFR 211.105(a)

Identification of containers, lines, equipment

Cited by Noreen Muniz, Alan P Kurtzberg

22 Mar 2019
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Noreen Muniz, Alan P Kurtzberg

22 Mar 2019
21 CFR 211.122(d)

Labels and labeling stored separately

Cited by Noreen Muniz, Alan P Kurtzberg

22 Mar 2019
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Noreen Muniz, Alan P Kurtzberg

22 Mar 2019
21 CFR 211.188

Prepared for each batch, include complete information

Cited by Noreen Muniz, Alan P Kurtzberg

Inspected site

BABayer AGLeverkusen, Germany

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.122(d)Cited across public-safe Form 483 observations3x
21 CFR 211.105(a)Cited across public-safe Form 483 observations2x
21 CFR 211.110(a)Cited across public-safe Form 483 observations2x
21 CFR 211.160(a)Cited across public-safe Form 483 observations2x
21 CFR 211.188Cited across public-safe Form 483 observations2x
21 CFR 211.67(b)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 13 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere